Search for: "Sanofi S A"
Results 1 - 20
of 923
Sorted by Relevance
|
Sort by Date
9 Nov 2010, 6:25 am
In the first one, Sanofi's CEO Christopher Viebacher sent a letter to Genzyme CEO Henri Termeer. [read post]
2 Aug 2012, 2:57 pm
In addition to finding Sanofi’s patent infringed, the Full Court affirmed Jagot J’s conclusion that Apotex had no implied licence to reproduce the copyright in Sanofi’s product information documents (PID). [read post]
1 Jun 2009, 9:03 pm
Sanofi-Aventis bought BiPar to obtain rights to BiPar's BSI-201, which belongs to a new class of drugs that block a cell repair enzyme known as PARP. [read post]
8 Feb 2007, 8:17 pm
Lovenox is Sanofi's best-selling drug, with sales of 2.14 billion euros ($2.75 billion) in 2005. [read post]
19 Feb 2023, 9:16 pm
Sanofi, in which Amgen seeks to have the Court overturn the District Court's grant of JMOL in the issue of whether Amgen's claims were invalid for non-enablement under 35 U.S.C. [read post]
18 Jul 2007, 8:41 am
Forbes noted: "Sanofi-Aventis has not yet been served with a complaint by Novo and our understanding of Novo's allegation is very preliminary,' a spokesman for Sanofi-Aventis told Thomson Financial. [read post]
8 May 2023, 8:43 pm
Sanofi. [read post]
30 Aug 2010, 5:12 am
Genzyme said Monday it rejected Sanofi's bid of $69 per share, after its board voted unanimously against the offer on Sunday night. [read post]
18 Jul 2012, 4:34 pm
Infringement The Court unanimously rejected Sanofi’s argument that the claim covered any administration of leflunomide which happened to (or also to) result in the treatment of psoriasis. [read post]
26 Nov 2010, 2:59 am
Henri Termeer of Genzyme told Le Figaro that he was not against Sanofi-Aventis's $18.5 billion takeover offer in principle, he just thinks it should be higher. [read post]
14 May 2023, 9:48 pm
Sanofi. [read post]
11 May 2023, 9:11 pm
Sanofi. [read post]
9 Nov 2011, 9:59 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and… [read post]
7 Nov 2008, 4:11 am
"Justice Marshall Rothstein concluded that selection patents "encourage improvements" and are therefore legitimate in their own right.In Sanofi's case, the company identified 250,000 possible chemical compounds in its original patent and later developed one into a better drug. [read post]
30 Jun 2010, 3:50 am
Sanofi-Aventis, France's largest drugmaker, agreed to buy closely held TargeGen to add treatments for certain forms of leukemia and blood disorders, Bloomberg News reported. [read post]
28 Jul 2010, 3:47 pm
Sanofi-Aventis is likely to make an unsolicited offer of up to $70 a share for Genzyme, raising the stakes for what could become one of the year's biggest deal situations, people briefed on the matter told DealBook on Wednesday. [read post]
1 Feb 2011, 11:38 am
Sanofi intends to add a few dollars a share to its $69-a-share offer, and will likely allow for additional payments to Genzyme shareholders if one of the company's drugs hits certain sales expectations. [read post]
10 May 2023, 12:15 pm
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
10 May 2023, 12:15 pm
Mylan Pharmaceuticals petitioned the PTAB for inter partes review (IPR) of all 18 claims in Sanofi’s drug injector pen patent. [read post]
26 Dec 2010, 9:59 pm
("Sanofi") following Sun's filing of an Abbreviated New Drug Application (ANDA) for generic oxaliplatin and Sanofi's filing of suit against Sun in response... [read post]
